Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110393102 | 11039310 | 2 | F | 20150414 | 20150416 | 20160907 | PER | US-GLAXOSMITHKLINE-US2015050425 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110393102 | 11039310 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 100/50 MCG 1 PUFF(S), QD | 4ZP4680 | 21077 | 1 | DF | INHALATION POWDER | QD | |||||
| 110393102 | 11039310 | 2 | SS | FLOVENT DISKUS | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | U | 0 | 1 | DF | QD | ||||||
| 110393102 | 11039310 | 3 | C | CHLOROPHYLL | 2 | 0 | |||||||||||||
| 110393102 | 11039310 | 4 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 110393102 | 11039310 | 5 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
| 110393102 | 11039310 | 6 | C | OREGANO OIL | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110393102 | 11039310 | 1 | Asthma |
| 110393102 | 11039310 | 2 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110393102 | 11039310 | Asthenia | |
| 110393102 | 11039310 | Candida infection | |
| 110393102 | 11039310 | Constipation | |
| 110393102 | 11039310 | Cough | |
| 110393102 | 11039310 | Depression | |
| 110393102 | 11039310 | Dysphonia | |
| 110393102 | 11039310 | Feeling abnormal | |
| 110393102 | 11039310 | Hypertension | |
| 110393102 | 11039310 | Ill-defined disorder | |
| 110393102 | 11039310 | Inappropriate schedule of drug administration | |
| 110393102 | 11039310 | Large intestine polyp | |
| 110393102 | 11039310 | Malaise | |
| 110393102 | 11039310 | Myalgia | |
| 110393102 | 11039310 | Nervousness | |
| 110393102 | 11039310 | Oral candidiasis | |
| 110393102 | 11039310 | Osteopenia | |
| 110393102 | 11039310 | Temperature intolerance | |
| 110393102 | 11039310 | Throat irritation | |
| 110393102 | 11039310 | Tremor | |
| 110393102 | 11039310 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110393102 | 11039310 | 1 | 2002 | 0 | ||
| 110393102 | 11039310 | 2 | 1998 | 0 |